2m 2m 2m 2m 2m 2m 2m
JOURNEY MEDICAL (DERM)
NASDAQ
$4.53+$0.09 (+2.03%)
Price as of Nov 12, 2026 8:21 AM EST- $98.7MMarket Cap
- -51.10%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
JOURNEY MEDICAL (DERM)
$4.53+$0.09 (+2.03%)
DERM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.44 | ||
Change | +$0.02 (+0.45%) | ||
Open | $4.43 | ||
High | $4.56 | ||
Low | $4.38 | ||
Previous Close | $4.42 | ||
Volume | 173,060 | ||
30-Day Average Volume | 191,170 | ||
1-Week Change | -6.13% | ||
1-Month Change | -29.64% | ||
1-Year Change | -51.10% | ||
3-Year Change | 19.03% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 22.2M | ||
Total Assets | $98.4M | ||
Market Cap | $98.7M | ||
Enterprise Value | $98.5M | ||
Period: QTR TTM FY | |||
Revenue | $18.5M | ||
Net Income | -$312,000.00 | ||
Free Cash Flow | -$1.7M | ||
EBIT | $609,000.00 | ||
EBITDA | $1.6M | ||
Net Working Capital | $27.0M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | 62 | ||
Enterprise Value/Revenue | 5 | ||
P/B | 3 | ||
P/E | -444 | ||
PEG | -5 | ||
Price/Free Cash Flow | -57 | ||
Price/Operating Cash Flow | -57 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue